Cargando…

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients

In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personalized therapy and to predict treatment response. We conducted a prospective study to evaluate the usefulness of circulating exosomal-PD-L1 in melanoma patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordonnier, Marine, Nardin, Charlée, Chanteloup, Gaëtan, Derangere, Valentin, Algros, Marie-Paule, Arnould, Laurent, Garrido, Carmen, Aubin, François, Gobbo, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968537/ https://www.ncbi.nlm.nih.gov/pubmed/32002173 http://dx.doi.org/10.1080/20013078.2019.1710899

Ejemplares similares

Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer
por: Vautrot, Valentin, et al.
Publicado: (2019)

Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours: a pilot study
por: Chanteloup, Gaétan, et al.
Publicado: (2020)

Nivolumab-induced capillary leak syndrome associated with chylothorax in a melanoma patient: A case report and review of the literature
por: Neuville, Carole, et al.
Publicado: (2022)

Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
por: Vautrot, Valentin, et al.
Publicado: (2021)

TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition
por: Marguier, Amélie, et al.
Publicado: (2022)

Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study
por: Chanteloup, Gaëtan, et al.
Publicado: (2020)

Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
por: Geoffrois, Lionnel, et al.
Publicado: (2023)

Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status
por: Morel, Louis-Oscar, et al.
Publicado: (2023)

Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis
por: Nardin, Charlée, et al.
Publicado: (2018)

Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells
por: Thuringer, Dominique, et al.
Publicado: (2017)

A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience – Franche Comté, France
por: Gallais-Serezal, Irène, et al.
Publicado: (2021)

The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7
por: Thuringer, Dominique, et al.
Publicado: (2018)

Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer
por: Klopfenstein, Quentin, et al.
Publicado: (2021)

PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
por: Tharin, Zoé, et al.
Publicado: (2023)

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
por: Simon, Sylvain, et al.
Publicado: (2020)

Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016
por: Colas, Morgane, et al.
Publicado: (2020)

Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
por: Galland, Loïck, et al.
Publicado: (2021)

Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
por: Reichert, Constance, et al.
Publicado: (2023)

Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization
por: Courtaut, Flavie, et al.
Publicado: (2015)

Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series
por: Niogret, Julie, et al.
Publicado: (2022)

Wegener's Granulomatosis: A Rare Cause of Hydronephrosis
por: Lillaz, Julien, et al.
Publicado: (2011)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018)

Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer
por: Boustani, Jihane, et al.
Publicado: (2020)

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2018)

Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status
por: Po, Joseph W., et al.
Publicado: (2019)

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2019)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
por: Del Re, Marzia, et al.
Publicado: (2018)

Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
por: Faure, Marjorie, et al.
Publicado: (2018)

Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use
por: Chevrier, Sandy, et al.
Publicado: (2022)

MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma
por: Eldh, Maria, et al.
Publicado: (2014)

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
por: Grapin, Mathieu, et al.
Publicado: (2019)

Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
por: Sharma, Priyanka, et al.
Publicado: (2018)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
por: De Almeida, Steven, et al.
Publicado: (2020)

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients’ Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)
por: Nardin, Charlée, et al.
Publicado: (2023)

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
por: Babačić, Haris, et al.
Publicado: (2020)

Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming
por: Gyukity-Sebestyén, Edina, et al.
Publicado: (2019)

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis
por: Sevin, Margaux, et al.
Publicado: (2018)

Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression
por: Warburton, Lydia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s6ushl58fqt6dr3roemci6eibs